Szekanecz, Zoltán http://orcid.org/0000-0002-7794-6844
Buch, Maya H. http://orcid.org/0000-0002-8962-5642
Charles-Schoeman, Christina
Galloway, James http://orcid.org/0000-0002-1230-2781
Karpouzas, George A. http://orcid.org/0000-0003-1065-1563
Kristensen, Lars Erik
Ytterberg, Steven R.
Hamar, Attila
Fleischmann, Roy http://orcid.org/0000-0002-6630-1477
Article History
Accepted: 28 November 2023
First Online: 12 January 2024
Change Date: 1 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41584-024-01085-w
Competing interests
: Z.S. declares that he has acted as a consultant for AbbVie, Lilly and Pfizer and has received research grants from Pfizer. M.H.B. declares that she has been a consultant for AbbVie, Galapagos and Pfizer. C.C.-S. declares that she has acted as a consultant for AbbVie, Galapagos and Pfizer and has received grants from AbbVie and Pfizer. J.G. declares that he has acted as a consultant for AbbVie, Galapagos, Lilly and Pfizer. G.A.K. declares that he has received research grants from Pfizer. L.E.K. declares that he has acted as a consultant for AbbVie, Galapagos, Lilly and Pfizer. S.R.Y. declares that he has acted as a consultant for Pfizer. R.F. declares that he has acted as a consultant for AbbVie, Galapagos, Lilly and Pfizer. A.H. declares no competing interests.